Intrinsic Value
Talis Biomedical Corporation (TLIS)
$8.9
+0.17 (+1.95%)
| Enterprise Value | -3,019,912.35 |
|---|---|
| Net Debt | -57.06 |
| Equity Value | -3,019,855.28 |
| Shares Outstanding | 1.82 |
| Equity Value Per Share | -1,661,538.00 |
Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt